152 related articles for article (PubMed ID: 33873053)
1. Helicobacter pylori infection and diabetes mellitus.
Polyzos SA; Papaefthymiou A; Doulberis M; Mavridoglou G; Kountouras J
Diabetes Metab Syndr; 2021; 15(3):845-846. PubMed ID: 33873053
[No Abstract] [Full Text] [Related]
2. Metabolic consequences of Helicobacter pylori infection and eradication.
Buzás GM
World J Gastroenterol; 2014 May; 20(18):5226-34. PubMed ID: 24833852
[TBL] [Abstract][Full Text] [Related]
3. Helicobacter pylori infection and diabetes: is it a myth or fact?
He C; Yang Z; Lu NH
World J Gastroenterol; 2014 Apr; 20(16):4607-17. PubMed ID: 24782613
[TBL] [Abstract][Full Text] [Related]
4. Randomized, double-blind, placebo-controlled trial to evaluate the effect of Helicobacter pylori eradication on glucose homeostasis in type 2 diabetic patients.
Bonfigli AR; Boemi M; Festa R; Bonazzi P; Brandoni G; Spazzafumo L; Olivieri F; Ceriello A; Genovese S; Testa R
Nutr Metab Cardiovasc Dis; 2016 Oct; 26(10):893-8. PubMed ID: 27480449
[TBL] [Abstract][Full Text] [Related]
5. Helicobacter pylori eradication rate and glycemic control in young patients with type 1 diabetes.
Candelli M; Rigante D; Marietti G; Nista EC; Crea F; Schiavino A; Cammarota G; Pignataro G; Petrucci S; Gasbarrini G; Gasbarrini A
J Pediatr Gastroenterol Nutr; 2004 Apr; 38(4):422-5. PubMed ID: 15085021
[TBL] [Abstract][Full Text] [Related]
6. Helicobacter pylori infection and diabetes mellitus: the 2013 state of art.
Marietti M; Gasbarrini A; Saracco G; Pellicano R
Panminerva Med; 2013 Sep; 55(3):277-81. PubMed ID: 24088801
[TBL] [Abstract][Full Text] [Related]
7. Cardio-cerebrovascular disease and Helicobacter pylori-related metabolic syndrome: We consider eradication therapy as a potential cardio-cerebrovascular prevention strategy.
Kountouras J; Polyzos SA; Katsinelos P; Zeglinas C; Artemaki F; Tzivras D; Vardaka E; Gavalas E; Romiopoulos I; Simeonidou C; Grigoriadis N; Kountouras C; Dardiotis E; Deretzi G
Int J Cardiol; 2017 Feb; 229():17-18. PubMed ID: 27887801
[No Abstract] [Full Text] [Related]
8. Increasing prevalence of primary clarithromycin resistance in Helicobacter pylori strains in Split, Croatia.
Tonkić A; Tonkić M; Brnić D
J Chemother; 2009 Nov; 21(5):598-9. PubMed ID: 19933055
[No Abstract] [Full Text] [Related]
9. Effect of Helicobacter pylori eradication on glycaemia control in patients with type 2 diabetes mellitus and comparison of two therapeutic regimens.
Vafaeimanesh J; Rajabzadeh R; Ahmadi A; Moshtaghi M; Banikarim S; Hajiebrahimi S; Seyyedmajidi M
Arab J Gastroenterol; 2013 Jun; 14(2):55-8. PubMed ID: 23820501
[TBL] [Abstract][Full Text] [Related]
10. [Helicobacter pylori and ulcer disease: diagnosis and treatment 1995].
Kayser S; Fried M
Praxis (Bern 1994); 1996 Sep; 85(39):1197-200. PubMed ID: 8927903
[TBL] [Abstract][Full Text] [Related]
11. Helicobacter pylori infection and diabetic complications.
Rossi C; Quadri R; Cavallo Perin P
Diabetes Nutr Metab; 2004 Feb; 17(1):65-8. PubMed ID: 15163129
[No Abstract] [Full Text] [Related]
12. [Helicobacter pylori infection: relationships between gastritis and clinical symptomatology].
Bruley Des Varannes S; Scarpignato C
Gastroenterol Clin Biol; 1996 Jan; 20(1 Pt 2):S84-S94. PubMed ID: 8734376
[No Abstract] [Full Text] [Related]
13. Predicting Helicobacter pylori eradication: how to teach an old dog new tricks!
Zullo A; De Francesco V; Hassan C
J Clin Gastroenterol; 2012 Apr; 46(4):259-61. PubMed ID: 22395061
[No Abstract] [Full Text] [Related]
14. [What are the consequences of untreated Helicobacter pylori infection?].
Iushchuk ND; Maev IV
Ter Arkh; 2008; 80(11):72-7. PubMed ID: 19143198
[No Abstract] [Full Text] [Related]
15. Antimicrobial resistance in Helicobacter pylori: current situation and management strategy in Vietnam.
Phan TN; Tran VH; Tran TN; Le VA; Santona A; Rubino S; Paglietti B
J Infect Dev Ctries; 2015 Jul; 9(6):609-13. PubMed ID: 26142670
[TBL] [Abstract][Full Text] [Related]
16. Eradication of Helicobacter pylori in nonulcer dyspepsia: how much analysis do we need?
McQuaid KR
J Clin Gastroenterol; 2003 Apr; 36(4):291-4. PubMed ID: 12642732
[No Abstract] [Full Text] [Related]
17. Prevalence of a marker of active helicobacter pylori infection among patients with type 2 diabetes mellitus in Lagos, Nigeria.
Oluyemi A; Anomneze E; Smith S; Fasanmade O
BMC Res Notes; 2012 Jun; 5():284. PubMed ID: 22686510
[TBL] [Abstract][Full Text] [Related]
18. Prevention of the metabolic syndrome insulin resistance and the atherosclerotic diseases in Africans infected by Helicobacter pylori infection and treated by antibiotics.
Longo-Mbenza B; Nkondi Nsenga J; Vangu Ngoma D
Int J Cardiol; 2007 Oct; 121(3):229-38. PubMed ID: 17368586
[TBL] [Abstract][Full Text] [Related]
19. Maintenance of Helicobacter pylori eradication rates with triple therapy over 12 years in a Spanish hospital.
Gisbert JP; McNicholl AG
Helicobacter; 2012 Apr; 17(2):160-1. PubMed ID: 22404448
[No Abstract] [Full Text] [Related]
20. Effect of Helicobacter pylori eradication on short-term control of glycemia in patients with type 2 diabetes mellitus.
Moghimi J; Toussy J; Babaei M; Mousavi S; Tamadon M; Karamai M
Saudi Med J; 2007 Mar; 28(3):475-6. PubMed ID: 17334489
[No Abstract] [Full Text] [Related]
[Next] [New Search]